These medications are generally considered a long term, potentially lifelong treatment, as Yet, 32% of people who begin taking GLP-1 weight loss medications stop within a year due to several reasons, including the high cost and severity of side effects
doi:10.1080/01635589409514302 Clinical, Cosmetic and Investigational Dermatology 2022:15 DovePress 1861 Dovepress Sharma and Sharma Powered by TCPDF (www.tcpdf.org) 39
Our experience shows this isn't a niche problem
Jin ES, Malloy CR, Sharma G, Finn E, Fuller KN, Reyes YG, et al
According to endocrinologists, the muscle loss during GLP-1 or semaglutide medication use is not unique to the drug its a consequence commonly seen in caloric restriction
Indeed, despite large heterogeneity in the studies (i.e